By Jonathan Capriel ( February 28, 2022, 2:56 PM EST) -- A California federal judge has given final approval to a $3.65 million class action settlement against StemGenex Medical Group Inc., a stem cell therapy provider that filed for Chapter 7 in 2019, for misleadingly marketing and selling treatments to patients suffering from "incurable diseases and a dearth of hope."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.